Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2020.9(1): 2024-2032
DOI: https://doi.org/10.20546/ijcmas.2020.901.229


Therapeutic Proteins Derived from Recombinant DNA Technology
Mabroukah Faraj El-Taher and Al-Yaqeen*
Medical Laboratory- Hoon city- Libya
Faculty of Medical technology-University of Al-jufra-Libya
*Corresponding author
Abstract:

The main  aim of this study is to critically investigate in current up-to-date the technology of rDNA and its biomedical applications as  therapeutic proteins. rDNA is the new technology and is a field of molecular biology where scientist reshape the DNA to form synthetic molecular that help to cure many diseases related to human being. A therapeutic proteins are proteins engineered in laboratory for pharmaceutical purpose, making of insulin is one of the most important benefits ever could be achieved by this technology. Therapeutic proteins are also used in different treatment such as Anemia, Hemophilia, Cancer, Hepatitis B and C and many more. A specific host cell like Bacteria is required to generate rDNA technology based protein.These proteins have a huge impact not only in disease related to human but also benefits agricultural and industry, on the other hand, there is a huge safety concerns affiliated with rDNA such as Virus's developing treatment  resistance. However, the future of rDNAproducts as therapeutic proteins is looking bright in term of new development in science and technology.


Keywords: Therapeutic Proteins
Recombinant DNA
Download this article as Download

How to cite this article:

Mabroukah Faraj El-Taher and Al-Yaqeen. 2020. Therapeutic Proteins Derived from Recombinant DNA Technology.Int.J.Curr.Microbiol.App.Sci. 9(1): 2024-2032. doi: https://doi.org/10.20546/ijcmas.2020.901.229